Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,446 | -40,598 | -6,381 | -195,625 | -187,969 |
| Depreciation Amortization | 37,150 | 24,875 | 11,785 | 57,365 | 44,900 |
| Income taxes - deferred | -8,609 | -8,098 | 81 | -2,377 | -3,540 |
| Accounts receivable | -4,874 | -21,933 | -1,958 | 10,055 | 19,247 |
| Other Working Capital | -9,672 | -9,214 | -14,757 | -3,181 | -5,156 |
| Other Operating Activity | 51,924 | 64,125 | 5,225 | 149,107 | 137,488 |
| Operating Cash Flow | $19,473 | $9,157 | $-6,005 | $15,344 | $4,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -432 | -368 | -291 | -7,362 | -6,993 |
| Net Acquisitions | N/A | N/A | N/A | 34,675 | 34,897 |
| Purchase Of Investment | -709 | -709 | -709 | N/A | 0 |
| Other Investing Activity | 0 | 0 | 0 | -11,506 | -11,506 |
| Investing Cash Flow | $-1,141 | $-1,077 | $-1,000 | $15,807 | $16,398 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 64,000 | 64,000 |
| Debt Repayment | -11,320 | -11,320 | -3,056 | -87,264 | -87,264 |
| Common Stock Issued | 1,339 | 786 | 177 | 778 | 620 |
| Other Financing Activity | -1,744 | -1,553 | -1,363 | -4,167 | -3,995 |
| Financing Cash Flow | $-11,725 | $-12,087 | $-4,242 | $-26,653 | $-26,639 |
| Exchange Rate Effect | -497 | -963 | -544 | 629 | 261 |
| Beginning Cash Position | 36,964 | 36,964 | 36,964 | 31,837 | 31,837 |
| End Cash Position | 43,074 | 31,994 | 25,173 | 36,964 | 26,827 |
| Net Cash Flow | $6,110 | $-4,970 | $-11,791 | $5,127 | $-5,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,473 | 9,157 | -6,005 | 15,344 | 4,970 |
| Capital Expenditure | -432 | -368 | -291 | -7,362 | -6,993 |
| Free Cash Flow | 19,041 | 8,789 | -6,296 | 7,982 | -2,023 |